Wellington Management Group LLP Boosts Holdings in Haleon plc (NYSE:HLN)

Wellington Management Group LLP increased its holdings in shares of Haleon plc (NYSE:HLN) by 67.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,328,325 shares of the company’s stock after buying an additional 6,175,835 shares during the period. Wellington Management Group LLP’s holdings in Haleon were worth $146,232,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in HLN. Douglas Lane & Associates LLC increased its position in shares of Haleon by 1.9% during the fourth quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock worth $82,274,000 after acquiring an additional 161,865 shares during the period. JPMorgan Chase & Co. grew its stake in Haleon by 18.3% during the 4th quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company’s stock worth $57,382,000 after purchasing an additional 930,701 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Haleon during the 4th quarter worth $42,193,000. Bank Julius Baer & Co. Ltd Zurich purchased a new stake in Haleon during the 4th quarter worth about $39,628,000. Finally, Van ECK Associates Corp raised its position in Haleon by 13.5% in the 4th quarter. Van ECK Associates Corp now owns 3,509,400 shares of the company’s stock valued at $33,480,000 after purchasing an additional 418,609 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently weighed in on HLN shares. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. HSBC reaffirmed a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Six investment analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $10.95.

Haleon Price Performance

Shares of HLN opened at $10.45 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 1-year low of $7.99 and a 1-year high of $10.80. The stock has a market cap of $47.29 billion, a PE ratio of 30.72, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. The firm has a fifty day moving average price of $10.02 and a 200 day moving average price of $9.87.

Haleon (NYSE:HLN) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, sell-side analysts anticipate that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The company also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This is an increase from Haleon’s previous — dividend of $0.05. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio is presently 58.97%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.